INVEST IN THE FUTURE OF STARTUPS
UC San Diego STARTUP INITIATIVE
Accelerating Innovations to Market (AIM) at the University of California San Diego
Support our next cohortGet in on the ground floor of a UC San Diego startup?
Let’s talk about how you can help.
How are your funded grants doing?
UC San Diego has built an ecosystem where grant recipients are in a early startup accelerator.
Have your seed investments done this?
Grant Awared -> 12 X return on investment
32 Patents filed
8 Startup companies
Case Study #1
Curescendo: measure blood pressure via ultrasonic skin patch
Highlights: Nature – One of 12 finalists for The Spinoff Prize 2020.
Read moreNew seed funding of over $1M from Welcome Trust, NIH, 3M and U54.
Case Study #2
Vektor Medical: non-invasive tool to detect ventricular fibrillation
5 year NIH funding over $3M.
Just completed successful Series A funding.Case Study #3
Veocor Diagnostics: AI-tech that analyzes echocardiogram to identify stroke risk
Over $640K in funding from American Heart Association, U54 and Medtronic.
AIM Leadership
Corinne Peek-Asa
Vice Chancellor for Research
Paul Roben
Associate Vice Chancellor for Innovation & Commercialization
Greg Horowitt
Director – Innovation Design
Shane Moise
Senior Manager for Strategic Innovation Alliances, Projects, and Data
What makes UC San Diego so special?
We have an ecosystem built for success with a go-to-market strategy.
#1
University of California system rank #1 in the world for international patent application.
#2
UC San Diego is second in the University of California system for highest number of US patents.
#3
Top University of California campus for the number of companies started.
KEY INVESTOR INCENTIVES
Access to researchers and rewarded high-potential, early-stage research projects
Cited in acknowledgements, gain access to different fields
Potential to pursue future licensing opportunities and become initial investors
Get in on the ground floor of a UC San Diego startup?
Let’s talk about how you can help.
[forminator_form id=”140″]
FAQ
Accelerating Innovations to Market (AIM) programs, through the Office of Innovation and Commercialization (OIC), are designed to accelerate the UC San Diego technologies to market and support the growth of startups.
AIM invites teams that include Active UCSD Faculty Member and students to submit a proposal. Tracks include the following:
Software-based healthcare technologies
Medical devices or diagnostics tools
Therapeutics, antibodies & small molecules
Pandemic preparedness
Women’s health
Microbiome interventions
Electroceutical therapies
Quantum Computing
Life Science Tech Development
Artificial Intelligence and digital platforms for healthcare and diagnostics
Oceanographic devices and tools
Seismographic and geologic interventions or tools
Energy, Smart Transportation, and IoT civic grid
Software and digital platforms
Equity, Diversity, and Inclusion are key parts of what makes AIM a successful program with enduring impact. AIM intentionally seeks to recruit and engage entrepreneurs and innovators from historically marginalized communities.
AIM holds an yearly competition to award several teams an amount in the range of $30,000 – $60,000 for one year. Please check our list of recent AIM award recipients.
https://innovation.ucsd.edu/stories/news-archives/2023/aim-awards-2023.html
Qualified proposals will have or be classified as the following:
- Early-stage proof-of-concept & feasibility projects
- Prototype development leading to field testing
- Requires UC San Diego IP
- A combination of UC San Diego and non-university IP is acceptable
Apply if you are or have any combination of the following:
- UC San Diego Faculty, Researchers, & Postdocs with team support
- UC San Diego Teams with an engineering or medical student engaged in the project
Preferences:
- UC San Diego IP (new disclosures accepted)
- Pre-company formation technologies
- Interdisciplinary approaches (multiple department involvement)
The program has been very successful. The projects have been multi-disciplinary and require a commitment to team science. Accumulating data (as of July 2019) show high ROI based on:
- Grants Awarded – 12X return on investment.
- Publications and Presentations at Conferences – 243.
- Patents Filed – 32.
- Start-up Companies – 8.
- Multiple new collaborations between engineers, clinical faculty, and industry.
- The University of California system is ranked #1 in the world for international patent applications.
- Partner with one of the top campuses for generating new companies.
- Receive additional benefits such as feedback and project direction, marketing ideas and strategic decisions from top scientists and engineers.